Progress in the experimental studies of traditional Chinese medicine for benign prostatic hyperplasia.
- Author:
Chunhe ZHANG
1
;
Yueqing LI
Author Information
1. Department of Urology and Andrology, Yunnan Hospital of Traditional Chinese Medicine, Kunming, Yunnan 650021, China.
- Publication Type:Journal Article
- MeSH:
Animals;
Disease Models, Animal;
Dogs;
Drugs, Chinese Herbal;
therapeutic use;
Humans;
Male;
Mice;
Phytotherapy;
Prostatic Hyperplasia;
drug therapy;
Rats
- From:
National Journal of Andrology
2004;10(12):949-951
- CountryChina
- Language:Chinese
-
Abstract:
The present article reviews the progress in the experimental studies of traditional Chinese medicine for benign prostatic hyperplasia (BPH) in the recent years. Traditional Chinese medicine can inhibit prostatic hyperplasia, after the growth factor of prostate cell proliferation, regulate nerves and endocrine, and act on the kinetic factor (alpha-receptor) and static factor (augmented prostate) of BPH formation. We also investigate the selection of the animal model of prostatic hyperplasia. It has certain directive effect to further discover the action mechanism of traditional Chinese medicine in the treatment of BPH.
